Where does Prolacta Bioscience, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Prolacta Bioscience, Inc. ranks #23,240 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Prolacta Bioscience, Inc. hold?

Prolacta Bioscience, Inc. holds 12 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Prolacta Bioscience, Inc.'s Innovation Score?

Prolacta Bioscience, Inc. has an Innovation Score of 36.4 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Prolacta Bioscience, Inc. focus on?

Prolacta Bioscience, Inc.'s top technology area is A23C (Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof) with 10 patents, ranking #27 of 208 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Prolacta Bioscience, Inc.'s patent grant rate increasing or decreasing?

Prolacta Bioscience, Inc.'s recent grant velocity is +167% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Prolacta Bioscience, Inc.'s patents?

Prolacta Bioscience, Inc.'s patents average 15.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Prolacta Bioscience, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Prolacta Bioscience, Inc.

USPTO PatentsView assignee record - 12 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23C (Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Prolacta ranks #23,240 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 8 technology areas.

#23,240
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.4/100): 15.4
avg claims per patent: +167%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23240 · US Corporation #23,240 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,240/49,997
PHOTO-FINISH Prevail Therapeutics
CPC-NARROW A23C · 8 areas
INNOV-THIN 36.4/100
CLAIMS-RICH 15.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +167% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Prevail Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Prolacta’s 36.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (24%) Velocity 8.3 pts (23%) Breadth 10.0 pts (27%) Claim depth 9.3 pts (25%)

Qualcomm Incorporated · highest

85
Prolacta Bioscience · this assignee

36
3D Lighting… · lowest

7

What this shows Prolacta's Innovation Score is 36.4/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Prolacta?

Each dot is one of Prolacta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Prolacta’s own 15.4 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Prolacta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Prolacta's grants concentrate

Prolacta Bioscience, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 83.3% of grants classified under A23C (Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2019. By volume, Prolacta sits between Prevail Therapeutics, Inc. and Pulselight Holdings, Inc..

Prolacta's three-year grant acceleration

Prolacta Bioscience, Inc. shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Prevail Therapeut…

12
Primed Halberstad…

12
Prinsco

12
Probiora Health

12
Promaxo

12
Psilo Scientific

12
Public Joint Stoc…

12
Pulselight Holdin…

12
Prolacta Bioscien… ◀

12

What this shows Prolacta holds 12 patents at rank #23,235, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Prolacta

By rank, the assignees closest to #23,235 in granted patent volume.

Leaders in A23C (Dairy Products)

Other assignees with the most granted patents in Prolacta's primary technology class.

Prolacta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Prolacta Bioscience, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	16.7%
2019	1	8.3%
2020	2	16.7%
2021	1	8.3%
2022	2	16.7%
2023	1	8.3%
2024	2	16.7%
2025partial year	1	8.3%

Which technologies does Prolacta Bioscience, Inc. patent most?

A23C - Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof 10

A23B - Preservation OF Foods, Foodstuffs OR Non-alcoholic BEVERAGES; Chemical Ripening OF Fruit OR Vegetables 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Prolacta Bioscience, Inc.'s patent record in context - here's where to go next.

Prolacta Bioscience, Inc.'s lead technology class is A23C (Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof), 83.3% of its portfolio - see every assignee active in that class. Explore A23C
Ranked #23,240 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Prolacta Bioscience, Inc. against Prevail Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.